Pelvic ultrasound, serum CA125 assay, CA19.9 assay and serum CA72.4 assay in the differential diagnosis of ovarian masses

A. Gadducci, P. Capriello, M. Ferdeghini, A. Madrigali, A. Puccetti, C. Annicchiarico, C. Prontera, R. Bianchi, P. Fioretti

Research output: Contribution to journalArticle

Abstract

Pelvic ultrasound, serum CA125 assay, serum CA19.9 assay and serum CA72.4 assay were preoperatively performed in 204 patients with ovarian masses undergoing laparotomy. All ultrasonogram examinations were scored using a personal morphological echostructural evaluation system. Each mass was graded between 0 and 16. Ultrasound score ≥8, serum CA125 levels ≥81 U/ml, CA19.9 ≥40 U/ml and serum CA72.4 levels ≥3.2 U/ml were respectively found in 51 (77.3%), 52 (78.8%), 22 (33.3%) and 48 (72.7%) of the 66 patients with ovarian carcinoma and in 10 (7.2%), 8 (5.8%), 26(18.8%) and 13 (9.4%) of the 138 patients with benign ovarian pathology. The combined evaluation of ultrasound, CA125 assay and CA19.9 assay had significantly higher sensitivity (94.2% vs 80.8% p = 0.0361) but not significantly lower specificity (81.5% vs 88.9% , p = NS) with respect to ultrasound alone in postmenopausal patients; in the same group of patients the association of ultrasound, CA125 assay and CA72.4 assay had significantly increased sensitivity (94.2% vs 80.8% , p = 0.0361) but not significantly decreased specificity (74.1% vs 88.9% , p = NS) when compared to ultrasound alone. In conclusion, the serum assay of CA125 and CA19.9 or CA72.4 seemed to improve the reliability of ultrasound in the differential diagnosis of ovarian masses in post-menopausal patients.

Original languageEnglish
Pages (from-to)249-253
Number of pages5
JournalCancer Journal (United States)
Volume4
Issue number4
Publication statusPublished - 1991

Fingerprint

Differential Diagnosis
Serum
Laparotomy
Pathology
Carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Gadducci, A., Capriello, P., Ferdeghini, M., Madrigali, A., Puccetti, A., Annicchiarico, C., ... Fioretti, P. (1991). Pelvic ultrasound, serum CA125 assay, CA19.9 assay and serum CA72.4 assay in the differential diagnosis of ovarian masses. Cancer Journal (United States), 4(4), 249-253.

Pelvic ultrasound, serum CA125 assay, CA19.9 assay and serum CA72.4 assay in the differential diagnosis of ovarian masses. / Gadducci, A.; Capriello, P.; Ferdeghini, M.; Madrigali, A.; Puccetti, A.; Annicchiarico, C.; Prontera, C.; Bianchi, R.; Fioretti, P.

In: Cancer Journal (United States), Vol. 4, No. 4, 1991, p. 249-253.

Research output: Contribution to journalArticle

Gadducci, A, Capriello, P, Ferdeghini, M, Madrigali, A, Puccetti, A, Annicchiarico, C, Prontera, C, Bianchi, R & Fioretti, P 1991, 'Pelvic ultrasound, serum CA125 assay, CA19.9 assay and serum CA72.4 assay in the differential diagnosis of ovarian masses', Cancer Journal (United States), vol. 4, no. 4, pp. 249-253.
Gadducci, A. ; Capriello, P. ; Ferdeghini, M. ; Madrigali, A. ; Puccetti, A. ; Annicchiarico, C. ; Prontera, C. ; Bianchi, R. ; Fioretti, P. / Pelvic ultrasound, serum CA125 assay, CA19.9 assay and serum CA72.4 assay in the differential diagnosis of ovarian masses. In: Cancer Journal (United States). 1991 ; Vol. 4, No. 4. pp. 249-253.
@article{b3428398d1ee4152a86fb6b1441f9bfc,
title = "Pelvic ultrasound, serum CA125 assay, CA19.9 assay and serum CA72.4 assay in the differential diagnosis of ovarian masses",
abstract = "Pelvic ultrasound, serum CA125 assay, serum CA19.9 assay and serum CA72.4 assay were preoperatively performed in 204 patients with ovarian masses undergoing laparotomy. All ultrasonogram examinations were scored using a personal morphological echostructural evaluation system. Each mass was graded between 0 and 16. Ultrasound score ≥8, serum CA125 levels ≥81 U/ml, CA19.9 ≥40 U/ml and serum CA72.4 levels ≥3.2 U/ml were respectively found in 51 (77.3{\%}), 52 (78.8{\%}), 22 (33.3{\%}) and 48 (72.7{\%}) of the 66 patients with ovarian carcinoma and in 10 (7.2{\%}), 8 (5.8{\%}), 26(18.8{\%}) and 13 (9.4{\%}) of the 138 patients with benign ovarian pathology. The combined evaluation of ultrasound, CA125 assay and CA19.9 assay had significantly higher sensitivity (94.2{\%} vs 80.8{\%} p = 0.0361) but not significantly lower specificity (81.5{\%} vs 88.9{\%} , p = NS) with respect to ultrasound alone in postmenopausal patients; in the same group of patients the association of ultrasound, CA125 assay and CA72.4 assay had significantly increased sensitivity (94.2{\%} vs 80.8{\%} , p = 0.0361) but not significantly decreased specificity (74.1{\%} vs 88.9{\%} , p = NS) when compared to ultrasound alone. In conclusion, the serum assay of CA125 and CA19.9 or CA72.4 seemed to improve the reliability of ultrasound in the differential diagnosis of ovarian masses in post-menopausal patients.",
author = "A. Gadducci and P. Capriello and M. Ferdeghini and A. Madrigali and A. Puccetti and C. Annicchiarico and C. Prontera and R. Bianchi and P. Fioretti",
year = "1991",
language = "English",
volume = "4",
pages = "249--253",
journal = "Cancer Journal from Scientific American",
issn = "1528-9117",
publisher = "Association Pour le Developpement de la Communication Cancerologique",
number = "4",

}

TY - JOUR

T1 - Pelvic ultrasound, serum CA125 assay, CA19.9 assay and serum CA72.4 assay in the differential diagnosis of ovarian masses

AU - Gadducci, A.

AU - Capriello, P.

AU - Ferdeghini, M.

AU - Madrigali, A.

AU - Puccetti, A.

AU - Annicchiarico, C.

AU - Prontera, C.

AU - Bianchi, R.

AU - Fioretti, P.

PY - 1991

Y1 - 1991

N2 - Pelvic ultrasound, serum CA125 assay, serum CA19.9 assay and serum CA72.4 assay were preoperatively performed in 204 patients with ovarian masses undergoing laparotomy. All ultrasonogram examinations were scored using a personal morphological echostructural evaluation system. Each mass was graded between 0 and 16. Ultrasound score ≥8, serum CA125 levels ≥81 U/ml, CA19.9 ≥40 U/ml and serum CA72.4 levels ≥3.2 U/ml were respectively found in 51 (77.3%), 52 (78.8%), 22 (33.3%) and 48 (72.7%) of the 66 patients with ovarian carcinoma and in 10 (7.2%), 8 (5.8%), 26(18.8%) and 13 (9.4%) of the 138 patients with benign ovarian pathology. The combined evaluation of ultrasound, CA125 assay and CA19.9 assay had significantly higher sensitivity (94.2% vs 80.8% p = 0.0361) but not significantly lower specificity (81.5% vs 88.9% , p = NS) with respect to ultrasound alone in postmenopausal patients; in the same group of patients the association of ultrasound, CA125 assay and CA72.4 assay had significantly increased sensitivity (94.2% vs 80.8% , p = 0.0361) but not significantly decreased specificity (74.1% vs 88.9% , p = NS) when compared to ultrasound alone. In conclusion, the serum assay of CA125 and CA19.9 or CA72.4 seemed to improve the reliability of ultrasound in the differential diagnosis of ovarian masses in post-menopausal patients.

AB - Pelvic ultrasound, serum CA125 assay, serum CA19.9 assay and serum CA72.4 assay were preoperatively performed in 204 patients with ovarian masses undergoing laparotomy. All ultrasonogram examinations were scored using a personal morphological echostructural evaluation system. Each mass was graded between 0 and 16. Ultrasound score ≥8, serum CA125 levels ≥81 U/ml, CA19.9 ≥40 U/ml and serum CA72.4 levels ≥3.2 U/ml were respectively found in 51 (77.3%), 52 (78.8%), 22 (33.3%) and 48 (72.7%) of the 66 patients with ovarian carcinoma and in 10 (7.2%), 8 (5.8%), 26(18.8%) and 13 (9.4%) of the 138 patients with benign ovarian pathology. The combined evaluation of ultrasound, CA125 assay and CA19.9 assay had significantly higher sensitivity (94.2% vs 80.8% p = 0.0361) but not significantly lower specificity (81.5% vs 88.9% , p = NS) with respect to ultrasound alone in postmenopausal patients; in the same group of patients the association of ultrasound, CA125 assay and CA72.4 assay had significantly increased sensitivity (94.2% vs 80.8% , p = 0.0361) but not significantly decreased specificity (74.1% vs 88.9% , p = NS) when compared to ultrasound alone. In conclusion, the serum assay of CA125 and CA19.9 or CA72.4 seemed to improve the reliability of ultrasound in the differential diagnosis of ovarian masses in post-menopausal patients.

UR - http://www.scopus.com/inward/record.url?scp=0025837499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025837499&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0025837499

VL - 4

SP - 249

EP - 253

JO - Cancer Journal from Scientific American

JF - Cancer Journal from Scientific American

SN - 1528-9117

IS - 4

ER -